|
1.
|
Adams JS and Hewison M: Update in vitamin
D. J Clin Endocrinol Metab. 95:471–478. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Adams JS and Hewison M: Extrarenal
expression of the 25-hydroxyvitamin D-1-hydroxylase. Arch Biochem
Biophys. 523:95–102. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Jones G: Extrarenal vitamin D activation
and interactions between vitamin D2, vitamin
D3, and vitamin D analogs. Annu Rev Nutr. 33:23–44.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Bikle DD: Vitamin D regulated keratinocyte
differentiation. J Cell Biochem. 92:436–444. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Oda Y, Chalkley RJ, Burlingame AL and
Bikle DD: The transcriptional coactivator DRIP/mediator complex is
involved in vitamin D receptor function and regulates keratinocyte
proliferation and differentiation. J Invest Dermatol.
130:2377–2388. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Bikle DD: Vitamin D and the skin. J Bone
Miner Metab. 28:117–130. 2010. View Article : Google Scholar
|
|
7.
|
Nagpal S, Na S and Rathnachalam R:
Noncalcemic actions of vitamin D receptor ligands. Endocr Rev.
26:662–687. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Xie Z, Komuves L, Yu QC, et al: Lack of
the vitamin D receptor is associated with reduced epidermal
differentiation and hair follicle growth. J Invest Dermatol.
118:11–16. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Ellison TI, Smith MK, Gilliam AC and
MacDonald PN: Inactivation of the vitamin D receptor enhances
susceptibility of murine skin to UV-induced tumorigenesis. J Invest
Dermatol. 128:2508–2517. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Zinser GM, Sundberg JP and Welsh J:
Vitamin D(3) receptor ablation sensitizes skin to chemically
induced tumorigenesis. Carcinogenesis. 23:2103–2109. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Bikle DD: The vitamin D receptor: a tumor
suppressor in skin. Discov Med. 11:7–17. 2011.PubMed/NCBI
|
|
12.
|
Bikle DD, Chang S, Crumrine D, et al: 25
Hydroxyvitamin D 1 alpha-hydroxylase is required for optimal
epidermal differentiation and permeability barrier homeostasis. J
Invest Dermatol. 122:984–992. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Boggess KA, Espinola JA, Moss K, Beck J,
Offenbacher S and Camargo CA Jr: Vitamin D status and periodontal
disease among pregnant women. J Periodontol. 82:195–200. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Giovannucci E, Liu Y, Rimm EB, et al:
Prospective study of predictors of vitamin D status and cancer
incidence and mortality in men. J Natl Cancer Inst. 98:451–459.
2006. View Article : Google Scholar
|
|
15.
|
Lipworth L, Rossi M, McLaughlin JK, et al:
Dietary vitamin D and cancers of the oral cavity and esophagus. Ann
Oncol. 20:1576–1581. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Winning TA and Townsend GC: Oral mucosal
embryology and histology. Clin Dermatol. 18:499–511. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Dickson MA, Hahn WC, Ino Y, et al: Human
keratinocytes that express hTERT and also bypass a
p16(INK4a)-enforced mechanism that limits life span become immortal
yet retain normal growth and differentiation characteristics. Mol
Cell Biol. 20:1436–1447. 2000. View Article : Google Scholar
|
|
18.
|
Wilkey JF, Buchberger G, Saucier K, et al:
Cyclin D1 overexpression increases susceptibility to
4-nitroquino-line-1-oxide-induced dysplasia and neoplasia in murine
squamous oral epithelium. Mol Carcinog. 48:853–861. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Owens DW, Brunton VG, Parkinson EK and
Frame MC: E-cadherin at the cell periphery is a determinant of
keratinocyte differentiation in vitro. Biochem Biophys Res Commun.
269:369–376. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Oda Y, Ishikawa MH, Hawker NP, Yun QC and
Bikle DD: Differential role of two VDR coactivators, DRIP205 and
SRC-3, in keratinocyte proliferation and differentiation. J Steroid
Biochem Mol Biol. 103:776–780. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Jiang YJ, Teichert AE, Fong F, Oda Y and
Bikle DD: 1alpha,25(OH)2-Dihydroxyvitamin D3/VDR protects the skin
from UVB-induced tumor formation by interacting with the
beta-catenin pathway. J Steroid Biochem Mol Biol. 136:229–232.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Nakagawa H, Wang TC, Zukerberg L, et al:
The targeting of the cyclin D1 oncogene by an Epstein-Barr virus
promoter in transgenic mice causes dysplasia in the tongue,
esophagus and forestomach. Oncogene. 14:1185–1190. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Reichrath J, Rafi L, Muller SM, et al:
Immunohistochemical analysis of 1,25-dihydroxyvitamin D3 receptor
in cervical carcinoma. Histochem J. 30:561–567. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Mitschele T, Diesel B, Friedrich M, et al:
Analysis of the vitamin D system in basal cell carcinomas (BCCs).
Lab Invest. 84:693–702. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Reichrath J, Rafi L, Rech M, et al:
Analysis of the vitamin D system in cutaneous squamous cell
carcinomas. J Cutan Pathol. 31:224–231. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Kostner K, Denzer N, Muller CS, Klein R,
Tilgen W and Reichrath J: The relevance of vitamin D receptor (VDR)
gene polymorphisms for cancer: a review of the literature.
Anticancer Res. 29:3511–3536. 2009.PubMed/NCBI
|
|
27.
|
Samander EH and Arnold A: Mutational
analysis of the vitamin D receptor does not support its candidacy
as a tumor suppressor gene in parathyroid adenomas. J Clin
Endocrinol Metab. 91:5019–5021. 2006. View Article : Google Scholar : PubMed/NCBI
|
